Hyalex Orthopaedics
Adam Gridley possesses extensive experience in leadership roles within the biopharmaceutical and medical device sectors. Currently serving as Chief Executive Officer of Allay Therapeutics since September 2020 and a member of the board at Hyalex Orthopaedics Inc. since February 2024, Gridley has previously held pivotal positions such as President & CEO of Histogenics and Senior Vice President at Merz North America and Merz Aesthetics. Transitioning through various strategic development roles at BioForm Medical and Gliatech, Gridley has consistently driven innovation in product development and business operations. Adam Gridley's academic foundation includes an MBA and a Bachelor's degree in Accounting from the University of Denver, further contributing to expertise in corporate strategy and operational execution.
This person is not in any teams
Hyalex Orthopaedics
Hyalex Orthopaedics is an Boston-area medical device company advancing new products that feature HYALEX™ technology, a polymer that is designed to mimic cartilage.